NEW YORK (GenomeWeb) – Cancer molecular profiling company Caris Life Sciences has been working on several new clinical assays and plans to submit its gene panel for approval by the US Food and Drug Administration.
Caris Life Sciences Developing New Assays, Planning to Seek FDA Approval for Cancer Profiling Test
Premium
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.